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n the article by Antman EM, Anbe DT, Armstrong PW, et al., “ACC/AHA guidelines for the management of patients
ith ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task
orce on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute
yocardial Infarction),” which appeared in the August 4, 2004, online issue of the journal (J Am Coll Cardiol
004;44:e1–212), the following corrections should be made to Table 15, page e53. All of these errors have been corrected
n the current online version of the article.
. In the “Reteplase” column, the “Dose” row, “ 2 each” should be replaced with “IV” and “(2nd dose 30 min after the
1st)” should be added immediately after “over 2 min” so that the line reads “10 U IV over 2 min (2nd dose 30 min after
the 1st)”.
. In the asterisk footnote, “Bolus 15 mg” should be changed to “Intravenous bolus 15 mg.”
. In the dagger footnote, (a) “Intravenous bolus over 5 sec” should be added at the beginning of the sentence and (b) “70-79
mg” should be changed to “70-79 kg” so that the entire footnote reads as follows: “Intravenous bolus over 5 sec, 30 mg
for weight less than 60 kg; 35 mg for 60-69 kg; 40 mg for 70-79 kg; 45 mg for 80-89 kg; 50 mg for 90 kg or more.”
doi:10.1016/j.jacc.2007.02.010
n “ACC/AHA Pocket Guideline Based on the ACC/AHAGuidelines for the Management of Patients With ST-Elevation
yocardial Infarction” (PDF available at http://www.acc.org), by Antman EM, Anbe DT, Armstrong PW, et al., the
ollowing correction should be made:
On page 44, Table 11, Tenecteplase, “IV bolus over 10-15 seconds” should be changed to “IV bolus over 5 seconds” and
70-79 mg” should be changed to “70-79 kg” so that the entire footnote reads as follows: “Tenecteplase, IV bolus over 5
econds, 30 mg for weight less than 60 kg; 35 mg for 60-69 kg; 40 mg for 70-79 kg; 45 mg for 80-89 kg; 50 mg for 90 kg
r more.”
doi:10.1016/j.jacc.2007.02.011
ostanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas
J, Anderson AA, Schollmeyer MP, Sobotka PA, for the UNLOAD Trial Investigators. Ultrafiltration Versus
ntravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure. J Am Coll Cardiol
007;49:675–83.
The lead author, Dr. Maria Rosa Costanzo, has surrendered all CHF Solutions stock options. Therefore, the disclosures
or this author should have read:
Dr. Maria Rosa Costanzo is a member of the Medical Advisory Board of CHF Solutions and receives Speaker’s honoraria
rom CHF Solutions.
doi:10.1016/j.jacc.2007.02.012
